Select Publications
Journal articles
2024, 'The Global Kidney Patient Trials Network and the CAPTIVATE Platform Clinical Trial Design: A Trial Protocol.', JAMA Netw Open, 7, pp. e2449998, http://dx.doi.org/10.1001/jamanetworkopen.2024.49998
,2024, 'Combination of the chemokine receptor type 2 (CCR2) antagonist DMX-200 and candesartan for COVID-19: a randomised controlled trial', BMJ open, 14, pp. e081790, http://dx.doi.org/10.1136/bmjopen-2023-081790
,2024, 'Kidney Disease as a Cardiovascular Disease Priority', Circulation, 150, pp. 975 - 977, http://dx.doi.org/10.1161/CIRCULATIONAHA.124.068242
,2024, 'Replacement Strategies for Tunneled Hemodialysis Catheters with Complications: A Nationwide Cohort Study', Clinical Journal of the American Society of Nephrology, 19, pp. 1148 - 1158, http://dx.doi.org/10.2215/CJN.0000000000000495
,2024, 'Machine learning for prediction of chronic kidney disease progression: Validation of the Klinrisk model in the CANVAS Program and CREDENCE trial', Diabetes, Obesity and Metabolism, 26, pp. 3371 - 3380, http://dx.doi.org/10.1111/dom.15678
,2024, 'Clinical Adjudication of Hemodialysis Catheter-Related Bloodstream Infections: Findings from the REDUCCTION Trial', Kidney360, 5, pp. 550 - 559, http://dx.doi.org/10.34067/KID.0000000000000389
,2024, 'Tunneled Hemodialysis Catheter Tip Design and Risk of Catheter Dysfunction: An Australian Nationwide Cohort Study', American Journal of Kidney Diseases, 83, pp. 445 - 455, http://dx.doi.org/10.1053/j.ajkd.2023.09.021
,2024, 'Barriers to Care: New Medications and CKD', Kidney International Reports, 9, pp. 504 - 507, http://dx.doi.org/10.1016/j.ekir.2023.12.012
,2024, 'Estimating the population-level impacts of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease: a cross-sectional observational study using routinely collected Australian primary care data', The Lancet Regional Health - Western Pacific, 43, http://dx.doi.org/10.1016/j.lanwpc.2023.100988
,2024, 'The Prevalence of CKD in Australian Primary Care: Analysis of a National General Practice Dataset', Kidney International Reports, 9, pp. 312 - 322, http://dx.doi.org/10.1016/j.ekir.2023.11.022
,2024, 'Anticoagulation for Patients with Atrial Fibrillation Receiving Dialysis', Journal of the American Society of Nephrology, http://dx.doi.org/10.1681/ASN.0000000000000495
,2024, 'Combination therapy with kidney protective therapies: Optimizing the benefits?', Current Opinion in Nephrology and Hypertension, 33, pp. 136 - 143, http://dx.doi.org/10.1097/MNH.0000000000000929
,2024, 'Effects of Semaglutide on CKD in Patients With Type 2 Diabetes', Kidney International Reports, http://dx.doi.org/10.1016/j.ekir.2024.11.1365
,2024, 'Assessing the Quality of Care for People with CKD: A Systematic Review and Meta-Analysis', Journal of the American Society of Nephrology, 35, http://dx.doi.org/10.1681/asn.2024bzcfkb63
,2024, 'Cardiovascular, Kidney, and Safety Outcomes with Canagliflozin in Older Adults: A Pooled Secondary Analysis of the CANVAS Program and CREDENCE Trial', Journal of the American Society of Nephrology, 35, http://dx.doi.org/10.1681/asn.2024e59ygyz9
,2024, 'National Estimates of Direct Health Care Costs Associated with Catheter-Related Bloodstream Infection among Hospitalized Hemodialysis Patients in Australia', Journal of the American Society of Nephrology, 35, http://dx.doi.org/10.1681/asn.20246pgrza9p
,2024, 'Risk-Based Implementation of SGLT2 Inhibitors: Insights from the CANVAS Program and CREDENCE Trial', Journal of the American Society of Nephrology, 35, http://dx.doi.org/10.1681/asn.2024k6fn2ax5
,2024, 'Use of SGLT2 Inhibitors and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists in Australian Primary Care Patients with Type 2 Diabetes Mellitus (T2DM) Stratified by CKD Status', Journal of the American Society of Nephrology, 35, pp. 10.1681/asn.2024f7q40fk1, http://dx.doi.org/10.1681/asn.2024f7q40fk1
,2024, 'WCN24-1868 ASSIST: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CROSSOVER TRIAL OF ATRASENTAN IN PATIENTS WITH IGA NEPHROPATHY (IGAN) ON SGLT2I', Kidney International Reports, 9, pp. S178 - S178, http://dx.doi.org/10.1016/j.ekir.2024.02.364
,2023, 'Effect of a Multifaceted Intervention on the Incidence of Hemodialysis Catheter Dysfunction in a National Stepped-Wedge Cluster Randomized Trial', Kidney International Reports, 8, pp. 1941 - 1950, http://dx.doi.org/10.1016/j.ekir.2023.07.013
,2023, 'Multifaceted Quality Improvement Interventions to Prevent Hemodialysis Catheter–Related Bloodstream Infections: A Systematic Review', American Journal of Kidney Diseases, 82, pp. 429 - 442.e1, http://dx.doi.org/10.1053/j.ajkd.2023.02.006
,2023, 'Medication use and hospital-acquired acute kidney injury: an electronic health record-based study', Internal Medicine Journal, 53, pp. 1625 - 1633, http://dx.doi.org/10.1111/imj.15938
,2023, '#4341 ASSIST STUDY DESIGN: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSSOVER STUDY OF ATRASENTAN IN PATIENTS WITH IGA NEPHROPATHY (IGAN) ON SGLT2I', Nephrology Dialysis Transplantation, 38, http://dx.doi.org/10.1093/ndt/gfad063c_4341
,2023, 'Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial', The Lancet, 401, pp. 1584 - 1594, http://dx.doi.org/10.1016/S0140-6736(23)00569-X
,2023, 'A Process Evaluation of the National Implementation of a Bundle for Central Venous Catheter Care for Hemodialysis', Kidney360, 4, pp. E496 - E504, http://dx.doi.org/10.34067/KID.0000000000000076
,2023, 'Electronic alerts and a care bundle for acute kidney injury - an Australian cohort study', Nephrology Dialysis Transplantation, 38, pp. 610 - 617, http://dx.doi.org/10.1093/ndt/gfac155
,2023, 'Burden of Haemodialysis Catheter-Related Bloodstream Infections in Australia: A National Data-Linkage Study', Journal of the American Society of Nephrology, 34, pp. 535 - 535, http://dx.doi.org/10.1681/asn.20233411s1535a
,2023, 'Hemodialysis Catheter Rewiring vs. Removal and Replacement: Post Hoc Analysis of a National Stepped Wedge Cluster Randomized Trial', Journal of the American Society of Nephrology, 34, pp. 534 - 535, http://dx.doi.org/10.1681/asn.20233411s1534c
,2023, 'Retrospective Audit of Patient Characteristics and Outcomes Following Review in a Specialist Hypertension Clinic', Heart, Lung and Circulation, 32, pp. S136 - S137, http://dx.doi.org/10.1016/j.hlc.2023.06.034
,2023, 'The Prevalence of CKD in Australian Primary Care: Analysis of a National General Practice Dataset', Journal of the American Society of Nephrology, 34, pp. 373 - 373, http://dx.doi.org/10.1681/asn.20233411s1373a
,2022, 'Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY disease (CLARITY): statistical analysis plan for a randomised controlled Bayesian adaptive sample size trial', Trials, 23, pp. 361, http://dx.doi.org/10.1186/s13063-022-06167-2
,2022, 'Should Corticosteroids Be Used to Treat Biopsy-Proven Drug-Induced Acute Interstitial Nephritis?: CON', Kidney360, 3, pp. 1310 - 1313, http://dx.doi.org/10.34067/KID.0007042021
,2022, 'Platform Clinical Trials Within Nephrology—Interpreting the Evidence', American Journal of Kidney Diseases, 80, pp. 143 - 146, http://dx.doi.org/10.1053/j.ajkd.2022.01.430
,2022, 'Retrospective study on the epidemiology of antineutrophil cytoplasmic autoantibodies-associated vasculitis in two Australian health districts', Internal Medicine Journal, 52, pp. 605 - 613, http://dx.doi.org/10.1111/imj.15098
,2022, 'Angiotensin receptor blockers for the treatment of covid-19: Pragmatic, adaptive, multicentre, phase 3, randomised controlled trial', BMJ, 379, pp. e072175, http://dx.doi.org/10.1136/bmj-2022-072175
,2022, 'Global Dialysis Perspective: Fiji', Kidney360, 3, pp. 164 - 167, http://dx.doi.org/10.34067/KID.0005652021
,2022, 'Impact of SGLT2 inhibitors on the kidney in people with type 2 diabetes and severely increased albuminuria', Expert Review of Clinical Pharmacology, 15, pp. 827 - 842, http://dx.doi.org/10.1080/17512433.2022.2108402
,2022, 'Multifaceted intervention to reduce haemodialysis catheter related bloodstream infections: REDUCCTION stepped wedge, cluster randomised trial', The BMJ, http://dx.doi.org/10.1136/bmj-2021-069634
,2022, 'Concordance Between Site Reporting and Clinical Adjudication of Catheter-Related Infectious Events in Australian and New Zealand Kidney Services', Journal of the American Society of Nephrology, 33, pp. 125 - 126, http://dx.doi.org/10.1681/asn.20223311s1125b
,2022, 'Multifaceted Interventions to Prevent Haemodialysis Catheter-Related Bloodstream Infections Outside the Intensive Care Unit: A Systematic Review and Meta-Analysis', Journal of the American Society of Nephrology, 33, pp. 124 - 124, http://dx.doi.org/10.1681/asn.20223311s1124b
,2022, 'Tunnelled Central Venous Haemodialysis Catheter Tip Design and Risk of Catheter Dysfunction', Journal of the American Society of Nephrology, 33, pp. 124 - 124, http://dx.doi.org/10.1681/asn.20223311s1124c
,2021, 'Protocol for the Controlled evaLuation of Angiotensin Receptor blockers for COVID-19 respIraTorY disease (CLARITY): a randomised controlled trial', Trials, 22, pp. 573, http://dx.doi.org/10.1186/s13063-021-05521-0
,2021, 'The kinetic estimated glomerular filtration rate ratio predicts acute kidney injury', Nephrology, 26, pp. 782 - 789, http://dx.doi.org/10.1111/nep.13918
,2021, 'Variability in estimated glomerular filtration rate and the risk of major clinical outcomes in diabetes: Post hoc analysis from the ADVANCE trial', Diabetes, Obesity and Metabolism, 23, pp. 1420 - 1425, http://dx.doi.org/10.1111/dom.14351
,2021, 'Forever starts now: Effects of glucose-lowering therapies on acute kidney injury', Clinical Journal of the American Society of Nephrology, 16, pp. 6 - 8, http://dx.doi.org/10.2215/CJN.18141120
,2021, 'The Impact of Clinical Presentation on Survival in Patients Requiring Hemodialysis Catheters for Acute and Unplanned Dialysis: A Prospective Observational Study', Canadian Journal of Kidney Health and Disease, 8, http://dx.doi.org/10.1177/20543581211009986
,2021, 'Clinical staff perspectives on the implementation of a national care bundle for care of Central venous catheters for haemodialysis', Infection, Disease & Health, 26, pp. S8 - S8, http://dx.doi.org/10.1016/j.idh.2021.09.029
,2020, 'Benchmarking Deep Learning Architectures for Predicting Readmission to the ICU and Describing Patients-at-Risk', Scientific Reports, 10, pp. 1111, http://dx.doi.org/10.1038/s41598-020-58053-z
,2020, 'Incidence of Ischaemic Heart Disease in Men and Women With End-Stage Kidney Disease: A Cohort Study', Heart Lung and Circulation, 29, pp. 1517 - 1526, http://dx.doi.org/10.1016/j.hlc.2020.03.002
,2020, 'SAFety, Effectiveness of care and Resource use among Australian Hospitals (SAFER Hospitals): A protocol for a population-wide cohort study of outcomes of hospital care', BMJ Open, 10, http://dx.doi.org/10.1136/bmjopen-2019-035446
,